Otonomy to Participate in Four Upcoming Investor Conferences

Back to Jobs

SAN DIEGO , Sept. 02, 2020 (GLOBE NEWSWIRE) — Otonomy , Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that management is scheduled to participate in four upcoming virtual investor conferences.

Apply Now